CE logo

Celanese (CE) EBITDA

annual EBITDA:

$503.00M-$2.14B(-80.96%)
December 31, 2024

Summary

  • As of today (May 18, 2025), CE annual EBITDA is $503.00 million, with the most recent change of -$2.14 billion (-80.96%) on December 31, 2024.
  • During the last 3 years, CE annual EBITDA has fallen by -$2.21 billion (-81.49%).
  • CE annual EBITDA is now -89.39% below its all-time high of $4.74 billion, reached on December 31, 2003.

Performance

CE EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCEincome statement metrics

quarterly EBITDA:

$358.00M+$1.52B(+130.70%)
March 31, 2025

Summary

  • As of today (May 18, 2025), CE quarterly EBITDA is $358.00 million, with the most recent change of +$1.52 billion (+130.70%) on March 31, 2025.
  • Over the past year, CE quarterly EBITDA has dropped by -$195.00 million (-35.26%).
  • CE quarterly EBITDA is now -78.79% below its all-time high of $1.69 billion, reached on December 31, 2020.

Performance

CE quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCEincome statement metrics

TTM EBITDA:

$308.00M-$195.00M(-38.77%)
March 31, 2025

Summary

  • As of today (May 18, 2025), CE TTM EBITDA is $308.00 million, with the most recent change of -$195.00 million (-38.77%) on March 31, 2025.
  • Over the past year, CE TTM EBITDA has dropped by -$2.41 billion (-88.65%).
  • CE TTM EBITDA is now -91.74% below its all-time high of $3.73 billion, reached on September 30, 2021.

Performance

CE TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCEincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CE EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-81.0%-35.3%-88.7%
3 y3 years-81.5%-52.7%-89.6%
5 y5 years-65.5%-11.8%-77.4%

CE EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-81.5%at low-66.8%+130.7%-89.6%at low
5 y5-year-81.5%at low-78.8%+130.7%-91.7%at low
alltimeall time-89.4%+1217.8%-78.8%+130.7%-91.7%+148.4%

CE EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$358.00M(-130.7%)
$308.00M(-38.8%)
Dec 2024
$503.00M(-81.0%)
-$1.17B(-307.8%)
$503.00M(-76.9%)
Sep 2024
-
$561.00M(+1.1%)
$2.17B(-19.2%)
Jun 2024
-
$555.00M(+0.4%)
$2.69B(-0.9%)
Mar 2024
-
$553.00M(+9.5%)
$2.71B(+2.7%)
Dec 2023
$2.64B(+14.7%)
$505.00M(-53.1%)
$2.64B(+10.3%)
Sep 2023
-
$1.08B(+86.0%)
$2.40B(+26.2%)
Jun 2023
-
$579.00M(+20.4%)
$1.90B(-6.4%)
Mar 2023
-
$481.00M(+86.4%)
$2.03B(-12.0%)
Dec 2022
$2.30B(-15.2%)
$258.00M(-55.5%)
$2.30B(-15.4%)
Sep 2022
-
$580.00M(-18.2%)
$2.72B(-5.4%)
Jun 2022
-
$709.00M(-6.3%)
$2.88B(-2.3%)
Mar 2022
-
$757.00M(+11.7%)
$2.95B(+8.5%)
Dec 2021
$2.72B(+0.0%)
$678.00M(-8.0%)
$2.72B(-27.1%)
Sep 2021
-
$737.00M(-5.1%)
$3.73B(+11.3%)
Jun 2021
-
$777.00M(+48.0%)
$3.35B(+18.1%)
Mar 2021
-
$525.00M(-68.9%)
$2.83B(+4.4%)
Dec 2020
$2.72B(+86.2%)
$1.69B(+370.2%)
$2.72B(+128.6%)
Sep 2020
-
$359.00M(+36.5%)
$1.19B(-6.8%)
Jun 2020
-
$263.00M(-35.2%)
$1.27B(-6.7%)
Mar 2020
-
$406.00M(+153.8%)
$1.36B(-6.4%)
Dec 2019
$1.46B(-26.5%)
$160.00M(-64.0%)
$1.46B(-8.5%)
Sep 2019
-
$445.00M(+25.7%)
$1.59B(-7.9%)
Jun 2019
-
$354.00M(-29.2%)
$1.73B(-10.7%)
Mar 2019
-
$500.00M(+69.5%)
$1.94B(-2.3%)
Dec 2018
$1.98B(+31.7%)
$295.00M(-49.3%)
$1.98B(-3.9%)
Sep 2018
-
$582.00M(+3.6%)
$2.06B(+9.5%)
Jun 2018
-
$562.00M(+3.1%)
$1.89B(+10.2%)
Mar 2018
-
$545.00M(+45.3%)
$1.71B(+13.5%)
Dec 2017
$1.51B(+4.3%)
$375.00M(-6.9%)
$1.51B(+8.5%)
Sep 2017
-
$403.00M(+3.9%)
$1.39B(+1.5%)
Jun 2017
-
$388.00M(+13.8%)
$1.37B(+0.6%)
Mar 2017
-
$341.00M(+32.7%)
$1.36B(-5.8%)
Dec 2016
$1.45B(+49.0%)
$257.00M(-32.9%)
$1.45B(+36.7%)
Sep 2016
-
$383.00M(+0.8%)
$1.06B(+4.7%)
Jun 2016
-
$380.00M(-10.6%)
$1.01B(+1.6%)
Mar 2016
-
$425.00M(-424.4%)
$994.00M(+2.5%)
Dec 2015
$970.00M(-30.0%)
-$131.00M(-139.0%)
$970.00M(-17.0%)
Sep 2015
-
$336.00M(-7.7%)
$1.17B(-9.8%)
Jun 2015
-
$364.00M(-9.2%)
$1.30B(-7.4%)
Mar 2015
-
$401.00M(+489.7%)
$1.40B(+0.9%)
Dec 2014
$1.39B
$68.00M(-85.3%)
$1.39B(-42.2%)
Sep 2014
-
$463.00M(-0.9%)
$2.40B(+4.9%)
Jun 2014
-
$467.00M(+20.4%)
$2.28B(+6.4%)
DateAnnualQuarterlyTTM
Mar 2014
-
$388.00M(-64.0%)
$2.15B(+2.2%)
Dec 2013
$2.10B(+154.2%)
$1.08B(+207.1%)
$2.10B(+134.9%)
Sep 2013
-
$351.00M(+6.4%)
$894.00M(+4.7%)
Jun 2013
-
$330.00M(-3.2%)
$854.00M(-7.7%)
Mar 2013
-
$341.00M(-366.4%)
$925.00M(+12.0%)
Dec 2012
$826.00M(-17.3%)
-$128.00M(-141.2%)
$826.00M(-7.7%)
Sep 2012
-
$311.00M(-22.4%)
$895.00M(-2.6%)
Jun 2012
-
$401.00M(+65.7%)
$919.00M(-1.3%)
Mar 2012
-
$242.00M(-510.2%)
$931.00M(-6.8%)
Dec 2011
$999.00M(-4.1%)
-$59.00M(-117.6%)
$999.00M(-24.3%)
Sep 2011
-
$335.00M(-18.9%)
$1.32B(+2.2%)
Jun 2011
-
$413.00M(+33.2%)
$1.29B(+6.1%)
Mar 2011
-
$310.00M(+18.3%)
$1.22B(+16.8%)
Dec 2010
$1.04B(+34.1%)
$262.00M(-14.4%)
$1.04B(+4.7%)
Sep 2010
-
$306.00M(-9.7%)
$995.00M(+13.8%)
Jun 2010
-
$339.00M(+151.1%)
$874.00M(+9.5%)
Mar 2010
-
$135.00M(-37.2%)
$798.00M(+3.4%)
Dec 2009
$777.00M(-26.4%)
$215.00M(+16.2%)
$772.00M(+8.3%)
Sep 2009
-
$185.00M(-29.7%)
$713.00M(-9.2%)
Jun 2009
-
$263.00M(+141.3%)
$785.00M(-4.4%)
Mar 2009
-
$109.00M(-30.1%)
$821.00M(-24.2%)
Dec 2008
$1.05B(-0.8%)
$156.00M(-39.3%)
$1.08B(-16.6%)
Sep 2008
-
$257.00M(-14.0%)
$1.30B(+1.9%)
Jun 2008
-
$299.00M(-19.4%)
$1.27B(+4.0%)
Mar 2008
-
$371.00M(0.0%)
$1.23B(+7.4%)
Dec 2007
$1.06B(+16.2%)
$371.00M(+59.2%)
$1.14B(+18.6%)
Sep 2007
-
$233.00M(-6.8%)
$962.00M(-2.1%)
Jun 2007
-
$250.00M(-12.9%)
$983.00M(-0.2%)
Mar 2007
-
$287.00M(+49.5%)
$985.00M(+4.8%)
Dec 2006
$916.00M(+12.7%)
$192.00M(-24.4%)
$940.00M(+14.1%)
Sep 2006
-
$254.00M(+0.8%)
$824.00M(+8.1%)
Jun 2006
-
$252.00M(+4.1%)
$762.00M(-0.3%)
Mar 2006
-
$242.00M(+218.4%)
$764.00M(-5.7%)
Dec 2005
$813.00M(+79.9%)
$76.00M(-60.4%)
$810.00M(-2.6%)
Sep 2005
-
$192.00M(-24.4%)
$832.00M(+0.8%)
Jun 2005
-
$254.00M(-11.8%)
$825.00M(+23.7%)
Mar 2005
-
$288.00M(+193.9%)
$667.00M(+32.6%)
Dec 2004
$452.00M(-90.5%)
$98.00M(-47.0%)
$503.00M(+24.2%)
Sep 2004
-
$185.00M(+92.7%)
$405.00M(+84.1%)
Jun 2004
-
$96.00M(-22.6%)
$220.00M(+77.4%)
Mar 2004
-
$124.00M
$124.00M
Dec 2003
$4.74B(+20.2%)
-
-
Dec 2002
$3.94B(-8864.4%)
-
-
Dec 2001
-$45.00M
-
-

FAQ

  • What is Celanese annual EBITDA?
  • What is the all time high annual EBITDA for Celanese?
  • What is Celanese annual EBITDA year-on-year change?
  • What is Celanese quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Celanese?
  • What is Celanese quarterly EBITDA year-on-year change?
  • What is Celanese TTM EBITDA?
  • What is the all time high TTM EBITDA for Celanese?
  • What is Celanese TTM EBITDA year-on-year change?

What is Celanese annual EBITDA?

The current annual EBITDA of CE is $503.00M

What is the all time high annual EBITDA for Celanese?

Celanese all-time high annual EBITDA is $4.74B

What is Celanese annual EBITDA year-on-year change?

Over the past year, CE annual EBITDA has changed by -$2.14B (-80.96%)

What is Celanese quarterly EBITDA?

The current quarterly EBITDA of CE is $358.00M

What is the all time high quarterly EBITDA for Celanese?

Celanese all-time high quarterly EBITDA is $1.69B

What is Celanese quarterly EBITDA year-on-year change?

Over the past year, CE quarterly EBITDA has changed by -$195.00M (-35.26%)

What is Celanese TTM EBITDA?

The current TTM EBITDA of CE is $308.00M

What is the all time high TTM EBITDA for Celanese?

Celanese all-time high TTM EBITDA is $3.73B

What is Celanese TTM EBITDA year-on-year change?

Over the past year, CE TTM EBITDA has changed by -$2.41B (-88.65%)
On this page